Avantor Inc (AVTR)

$25.48

+2.66

(+11.66%)▲

Live

Performance

  • $24.51
    $25.87
    $25.48
    downward going graph

    3.81%

    Downside

    Day's Volatility :5.26%

    Upside

    1.51%

    downward going graph
  • $16.63
    $26.11
    $25.48
    downward going graph

    34.73%

    Downside

    52 Weeks Volatility :36.31%

    Upside

    2.41%

    downward going graph

Returns

PeriodAvantor IncSector (Health Care)Index (Russel 2000)
3 Months
-4.68%
6.5%
0.0%
6 Months
0.71%
7.1%
0.0%
1 Year
-2.19%
9.8%
0.0%
3 Years
-38.11%
14.2%
-20.2%

Highlights

Market Capitalization
14.4B
Book Value
$7.86
Earnings Per Share (EPS)
0.38
PE Ratio
55.71
Wall Street Target Price
26.49
Profit Margin
3.79%
Operating Margin TTM
8.73%
Return On Assets TTM
3.88%
Return On Equity TTM
5.03%
Revenue TTM
6.9B
Revenue Per Share TTM
10.15
Quarterly Revenue Growth YOY
-5.6000000000000005%
Gross Profit TTM
2.6B
EBITDA
1.2B
Diluted Eps TTM
0.38
Quarterly Earnings Growth YOY
-0.5
EPS Estimate Current Year
1.0
EPS Estimate Next Year
1.21
EPS Estimate Current Quarter
0.2
EPS Estimate Next Quarter
0.24

Analyst Recommendation

Buy
    68%Buy
    27%Hold
    3%Sell
Based on 29 Wall street analysts offering stock ratings for Avantor Inc(by analysts ranked 0 to 5 stars)
Based on 29 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
20
20
20
Hold
8
9
9
Sell
1
00
00

Analyst Forecast

What analysts predicted

Upside of 3.96%

Current $25.48
Target $26.49

Company Financials

FY18Y/Y Change
Revenue
5.9B
↑ 370.12%
Net Income
-86.9M
↓ 22.89%
Net Profit Margin
-1.48%
↑ 7.55%
FY19Y/Y Change
Revenue
6.0B
↑ 3.0%
Net Income
37.8M
↓ 143.5%
Net Profit Margin
0.63%
↑ 2.11%
FY20Y/Y Change
Revenue
6.4B
↑ 5.85%
Net Income
116.6M
↑ 208.47%
Net Profit Margin
1.82%
↑ 1.19%
FY21Y/Y Change
Revenue
7.4B
↑ 15.52%
Net Income
572.6M
↑ 391.08%
Net Profit Margin
7.75%
↑ 5.93%
FY22Y/Y Change
Revenue
4.9B
↓ 33.53%
Net Income
686.5M
↑ 19.89%
Net Profit Margin
13.98%
↑ 6.23%
FY23Y/Y Change
Revenue
7.0B
↑ 41.91%
Net Income
321.1M
↓ 53.23%
Net Profit Margin
4.61%
↓ 9.37%
Q4 FY22Q/Q Change
Revenue
7.5B
↑ 304.65%
Net Income
94.0M
↓ 43.71%
Net Profit Margin
1.25%
↓ 7.75%
Q1 FY23Q/Q Change
Revenue
1.8B
↓ 76.3%
Net Income
121.5M
↑ 29.26%
Net Profit Margin
6.82%
↑ 5.57%
Q2 FY23Q/Q Change
Revenue
1.7B
↓ 2.04%
Net Income
-7.3M
↓ 106.01%
Net Profit Margin
-0.42%
↓ 7.24%
Q3 FY23Q/Q Change
Revenue
1.7B
↓ 1.36%
Net Income
108.4M
↓ 1584.93%
Net Profit Margin
6.3%
↑ 6.72%
Q4 FY23Q/Q Change
Revenue
1.7B
↑ 0.15%
Net Income
98.5M
↓ 9.13%
Net Profit Margin
5.72%
↓ 0.58%
Q1 FY24Q/Q Change
Revenue
1.7B
↓ 2.5%
Net Income
60.4M
↓ 38.68%
Net Profit Margin
3.6%
↓ 2.12%
FY18Y/Y Change
Total Assets
9.9B
↓ 5.12%
Total Liabilities
13.0B
↓ 0.79%
FY19Y/Y Change
Total Assets
9.8B
↓ 1.4%
Total Liabilities
7.3B
↓ 43.6%
FY20Y/Y Change
Total Assets
9.9B
↑ 1.36%
Total Liabilities
7.2B
↓ 1.08%
FY21Y/Y Change
Total Assets
13.9B
↑ 40.28%
Total Liabilities
9.7B
↑ 34.13%
FY22Y/Y Change
Total Assets
13.5B
↓ 3.12%
Total Liabilities
8.6B
↓ 11.25%
FY23Y/Y Change
Total Assets
13.0B
↓ 3.65%
Total Liabilities
7.7B
↓ 10.32%
Q4 FY22Q/Q Change
Total Assets
13.5B
↑ 2.68%
Total Liabilities
8.6B
↑ 1.02%
Q1 FY23Q/Q Change
Total Assets
13.4B
↓ 0.51%
Total Liabilities
8.4B
↓ 2.41%
Q2 FY23Q/Q Change
Total Assets
13.1B
↓ 2.48%
Total Liabilities
8.1B
↓ 4.16%
Q3 FY23Q/Q Change
Total Assets
12.8B
↓ 2.03%
Total Liabilities
7.7B
↓ 4.39%
Q4 FY23Q/Q Change
Total Assets
13.0B
↑ 1.36%
Total Liabilities
7.7B
↑ 0.28%
Q1 FY24Q/Q Change
Total Assets
12.8B
↓ 1.61%
Total Liabilities
7.4B
↓ 3.8%
FY18Y/Y Change
Operating Cash Flow
200.5M
↓ 219.7%
Investing Cash Flow
-23.2M
↓ 99.65%
Financing Cash Flow
-170.3M
↓ 102.45%
FY19Y/Y Change
Operating Cash Flow
354.0M
↑ 76.56%
Investing Cash Flow
-42.1M
↑ 81.47%
Financing Cash Flow
-307.8M
↑ 80.74%
FY20Y/Y Change
Operating Cash Flow
929.8M
↑ 162.66%
Investing Cash Flow
-59.1M
↑ 40.38%
Financing Cash Flow
-782.9M
↑ 154.35%
FY21Y/Y Change
Operating Cash Flow
953.6M
↑ 2.56%
Investing Cash Flow
-4.1B
↑ 6874.11%
Financing Cash Flow
3.2B
↓ 511.19%
FY22Y/Y Change
Operating Cash Flow
843.6M
↓ 11.54%
Investing Cash Flow
-109.6M
↓ 97.34%
Financing Cash Flow
-648.7M
↓ 120.15%
Q4 FY22Q/Q Change
Operating Cash Flow
205.6M
↓ 20.4%
Investing Cash Flow
-33.1M
↓ 907.32%
Financing Cash Flow
-81.6M
↓ 62.81%
Q1 FY23Q/Q Change
Operating Cash Flow
219.5M
↑ 6.76%
Investing Cash Flow
-27.3M
↓ 17.52%
Financing Cash Flow
-275.0M
↑ 237.01%
Q2 FY23Q/Q Change
Operating Cash Flow
168.2M
↓ 23.37%
Investing Cash Flow
-29.4M
↑ 7.69%
Financing Cash Flow
-196.2M
↓ 28.65%
Q3 FY23Q/Q Change
Operating Cash Flow
230.7M
↑ 37.16%
Investing Cash Flow
-37.0M
↑ 25.85%
Financing Cash Flow
-188.4M
↓ 3.98%

Technicals Summary

Sell

Neutral

Buy

Avantor Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avantor Inc
Avantor Inc
3.96%
0.71%
-2.19%
-38.11%
26.71%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-1.92%
-1.24%
-14.64%
-10.54%
12.18%
Linde Plc
Linde Plc
1.05%
9.65%
14.12%
48.43%
120.46%
Dupont De Nemours Inc
Dupont De Nemours Inc
-1.25%
22.21%
3.13%
5.87%
7.95%
Sherwin-williams Company, The
Sherwin-williams Company, The
15.46%
13.55%
22.01%
20.06%
100.71%
Ecolab Inc.
Ecolab Inc.
1.25%
22.76%
28.95%
11.19%
22.06%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avantor Inc
Avantor Inc
55.71
55.71
NA
1.0
0.05
0.04
NA
7.86
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
23.39
23.39
1.37
12.23
0.16
0.05
0.03
67.08
Linde Plc
Linde Plc
34.48
34.48
2.65
15.49
0.16
0.07
0.01
80.78
Dupont De Nemours Inc
Dupont De Nemours Inc
86.51
86.51
1.64
3.63
0.02
0.03
0.02
56.41
Sherwin-williams Company, The
Sherwin-williams Company, The
33.78
33.78
4.16
11.45
0.68
0.1
0.01
14.95
Ecolab Inc.
Ecolab Inc.
45.45
45.45
2.33
6.57
0.2
0.07
0.01
23.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avantor Inc
Avantor Inc
Buy
$14.4B
26.71%
55.71
3.79%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$57.5B
12.18%
23.39
20.32%
Linde Plc
Linde Plc
Buy
$213.3B
120.46%
34.48
19.26%
Dupont De Nemours Inc
Dupont De Nemours Inc
Buy
$33.3B
7.95%
86.51
2.96%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$83.8B
100.71%
33.78
10.92%
Ecolab Inc.
Ecolab Inc.
Hold
$70.1B
22.06%
45.45
10.01%

Insights on Avantor Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.72B → 1.67B (in $), with an average decrease of 2.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 108.4M → 60.4M (in $), with an average decrease of 23.9% per quarter

  • Vs ECL

    In the last 1 year, Ecolab Inc. has given 28.9% return, outperforming this stock by 31.1%

  • Vs LIN

    In the last 3 years, Linde Plc has given 11.2% return, outperforming this stock by 49.3%

Institutional Holdings

  • Vanguard Group Inc

    9.49%

  • Dodge & Cox

    9.37%

  • T. Rowe Price Investment Management,Inc.

    7.52%

  • BlackRock Inc

    6.30%

  • Boston Partners Global Investors, Inc

    4.20%

  • Barrow Hanley Mewhinney & Strauss LLC

    3.47%

Company Information

based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com

Organization
Avantor Inc
Employees
14500
CEO
Mr. Michael Stubblefield
Industry
Chemicals: Specialty

Discover More

FAQs